Decrease in C-reactive protein levels in rabbits after vaccination with a live attenuated myxoma virus vaccine L., Parkanyi V., Vasicek J., Jurcik R., Hanusova E., Vasicek D., Balazi A., Vizzarri F. (2016): Decrease in C-reactive protein levels in rabbits after vaccination with a live attenuated myxoma virus vaccine. Veterinarni Medicina, 61: 571-576.
download PDF
The aim of this study was to evaluate the acute phase reaction and immune response of rabbits triggered by vaccination with a live attenuated myxoma virus (MXT) vaccine. Thirteen adult and 11 juvenile New Zealand white rabbit-based crossbreed rabbits, were used. Samples of rabbit peripheral blood were collected from vena auricularis centralis into heparinised tubes before vaccination and 48 h after vaccination. All animals were vaccinated by subcutaneous injection (0.5 ml) with a MXT vaccine. The blood plasma C-reactive protein level was measured by an ELISA kit using a double-antibody sandwich. For phenotyping of lymphocytes the fresh cells were stained with the following anti-rabbit monoclonal antibodies: anti-IgM, anti-CD4, anti-CD8 and anti-pan T2. Our results show that the use of attenuated myxoma virus vaccine significantly decreases the level of C-reactive protein in blood plasma of adult rabbits by 38.14% (P < 0.05) and of juvenile rabbits by 37.63% (P < 0.001), within 48 h. The rabbit C-reactive protein after MXT vaccination is a negative acute phase protein. In the group of adult rabbits the immune response to MXT vaccination was accompanied by a non-significant decrease in CD4+, pT2+, IgM+ subsets. On the other hand the values of CD8+, CD4+CD8+ and CD4+/CD8+ were non-significantly higher after MXT vaccination.
Barry M, Lee SF, Boshkov L, McFadden G (1995): Myxoma virus induces extensive CD4 downregulation and dissociation of p56lck in infected rabbit CD41 T lymphocytes. Journal of Virology 69, 5243–5251.
Best Sonja M., Kerr Peter J. (2000): Coevolution of Host and Virus: The Pathogenesis of Virulent and Attenuated Strains of Myxoma Virus in Resistant and Susceptible European Rabbits. Virology, 267, 36-48
Brahn Ernest, Lee Sarah, Lucas Alexandra, McFadden Grant, Macaulay Colin (2014): Suppression of collagen-induced arthritis with a serine proteinase inhibitor (serpin) derived from myxoma virus. Clinical Immunology, 153, 254-263
Destexhe Eric, Prinsen Menk K., van Schöll Inge, Kuper C. Frieke, Garçon Nathalie, Veenstra Stéphane, Segal Lawrence (2013): Evaluation of C-reactive protein as an inflammatory biomarker in rabbits for vaccine nonclinical safety studies. Journal of Pharmacological and Toxicological Methods, 68, 367-373
Du Clos TW, Mold C (2003): 3 C-reactive protein: structure, synthesis and function. In: Wong S, Arsequell G (eds): Immunobiology of Carbohydrates. Kluwer Academic/Plenum Publishers, New York. 47–61.
Faldyna Martin, Levá Lenka, Knötigová Pavlı́na, Toman Miroslav (2001): Lymphocyte subsets in peripheral blood of dogs — a flow cytometric study. Veterinary Immunology and Immunopathology, 82, 23-37
Finkelman Fred D., Holmes Joanne, Katona Ildy M, Urban Joseph F., Beckmann M. Patricia, Park Linda S., Schooley Kenneth A., Coffman Robert L., Mosmann Timothy R., Paul William E. (1990): Lymphokine Control of in Vivo Immunoglobulin Isotype Selection. Annual Review of Immunology, 8, 303-333
Epstein Franklin H., Gabay Cem, Kushner Irving (1999): Acute-Phase Proteins and Other Systemic Responses to Inflammation. New England Journal of Medicine, 340, 448-454
Jackson RJ, Hall DF, Kerr PJ (1999): Myxoma virus encodes an alpha 2,3-sialyltransferase that enhances virulence. Journal of Virology 73, 2376–2384.
Jain Sachin, Gautam Vidhi, Naseem Sania (2011): Acute-phase proteins: As diagnostic tool. Journal of Pharmacy and Bioallied Sciences, 3, 118-
Jeklova Edita, Leva Lenka, Faldyna Martin (2007): Lymphoid organ development in rabbits: Major lymphocyte subsets. Developmental & Comparative Immunology, 31, 632-644
Jeklova Edita, Leva Lenka, Matiasovic Jan, Kovarcik Kamil, Kudlackova Hana, Nevorankova Zora, Psikal Ivan, Faldyna Martin (2008): Characterisation of immunosuppression in rabbits after infection with myxoma virus. Veterinary Microbiology, 129, 117-130
Kelso Anne, Troutt Anthony B., Maraskovsky Eugene, Gough Nicholas M., Morris Lynn, Pech Michael H., Thomson Jennifer A. (1991): Heterogeneity in Lymphokine Profiles of CD4 + and CD8 + T Cells and Clones Activated in vivo and in vitro. Immunological Reviews, 123, 85-114
Lanning D., Sethupathi P., Rhee K.-J., Zhai S.-K., Knight K. L. (): Intestinal Microflora and Diversification of the Rabbit Antibody Repertoire. The Journal of Immunology, 165, 2012-2019
Lomas DA, Evans DL, Upton C, McFadden G, Carrell RW (1993): Inhibition of plasmin, urokinase, tissue plasminogen activator, and C1S by a myxoma virus serine proteinase inhibitor. Journal of Biological Chemistry 268, 516–521.
McFadden Grant, Barry Michele (1998): How Poxviruses Oppose Apoptosis. Seminars in Virology, 8, 429-442
Messud-Petit F, Gelfi J, Delverdier M, Amardeilh MF, Py R, Sutter G, Bertagnoli S (1998): Serp2, an inhibitor of the interleukin-1β-converting enzyme, is critical in the pathobiology of myxoma virus. Journal of Virology 72, 7830–7839.
Mosmann T R, Coffman R L (1989): TH1 and TH2 Cells: Different Patterns of Lymphokine Secretion Lead to Different Functional Properties. Annual Review of Immunology, 7, 145-173
Nash P., Whitty A., Handwerker J., Macen J., McFadden G. (): Inhibitory Specificity of the Anti-inflammatory Myxoma Virus Serpin, SERP-1. Journal of Biological Chemistry, 273, 20982-20991
Nash Piers, Barrett John, Cao Jing-Xin, Hota-Mitchell Sheela, Lalani Alshad S., Everett Helen, Xu Xiao-Ming, Robichaud Janine, Hnatiuk Shawna, Ainslie Cheryl, Seet Bruce T., McFadden Grant (1999): Immunomodulation by viruses: the myxoma virus story. Immunological Reviews, 168, 103-120
Nossal Gustav JV (1997): Host immunobiology and vaccine development. The Lancet, 350, 1316-1319
Petit F, Bertagnoli S, Gelfi J, Fassy F, Boucraut-Baralon C, Milon A (1996): Characterization of a myxoma virus-encoded serpin-like protein with activity against interleukin-1β-converting enzyme. Journal of Virology 70, 5860–5866.
Spiesschaert Bart, McFadden Grant, Hermans Katleen, Nauwynck Hans, Van de Walle Gerlinde R (2011): The current status and future directions of myxoma virus, a master in immune evasion. Veterinary Research, 42, 76-
Strayer DS (1992): Determinants of virus-related suppression of immune responses as observed during infection with an oncogenic poxvirus. Progress in Medical Virology 39, 228–255.
Strayer David S., Skaletsky Eileen, Leibowitz Julian L., Dombrowski Jan (1987): Growth of malignant rabbit fibroma virus in lymphoid cells. Virology, 158, 147-157
Tokarz-Deptula B, Deptula W (2005): Values of selected immune and haematological parameters in healthy rabbits. Polish Journal of Veterinary Sciences 8, 107–112.
Tothova C, Nagy O, Kovac G (2014): Acute phase proteins and their use in the diagnosis of diseases in ruminants: a review. Veterinarni Medicina 59, 163–180.
Turner Peter C., Moyer Richard W. (1998): Control of Apoptosis by Poxviruses. Seminars in Virology, 8, 453-469
Vajdy M, Sethupathi P, Knight KL (1998): Dependence of antibody somatic diversification on gut-associated lymphoid tissue in rabbits. Journal of Immunology 160, 2725–2729.
Watzinger M., Nguyen A., Gervais F., Lemarchand T., Legrand J., Descotes J. (2011): Evaluation of inflammation biomarkers for safety assessment of vaccines and adjuvants in the rabbit. Toxicology Letters, 205, S113-S114
download PDF

© 2022 Czech Academy of Agricultural Sciences | Prohlášení o přístupnosti